|
Hi Phyllis. I'm several years out as a Stage I Grade 3 node-negative HER2+++, IDC 1.6. Didn't qualify for the clinical trial when newly diagnosed. Can't have it now by the vague consensus among oncologists.
Does anybody have any clues as to why the national consensus of oncologists at time of diagnosis was that I wasn't at enough risk to be in the clinical trial, but that I was at enough risk that I needed to have chemo with Adriamycin, then rads, and then be blasted into menopause (including ruining my sex life) with hormonal treatment that is uncomfortable for the rest of my life?
Could it have anything to do with the fact that the number of oncologists who have personally been through treatment (OR recurrence) is probably close to zero?
If you can get it, more power to you.
AlaskaAngel
|